Beryl Keeley has a background in biochemistry and has worked in various areas in Government and previously in the pharmaceutical industry. Currently Beryl is Advertising Standards Unit Manager within the Access and Information for Medicines and Standards (AIMS) Group at the Medicines and Healthcare products Regulatory Agency with responsibility for the regulation of medicines advertising.

Claire has recently taken up the post of Advertising Standards and Outreach Unit Manager, having previously worked in this team as the managing editor of Drug Safety Update – the MHRA’s safety bulletin for healthcare professionals. This team aims to ensure that healthcare professionals and the wider public have access to good-quality information about medicines to support safer use. Claire has worked at the Agency for over 10 years in the area of risk communications, helping to draft and release safety information for healthcare professionals and patients on a wide range of topics and medicines. Before coming to the Agency, she studied an MSc in Science Culture and Communication before joining the editorial team at the Lancet group of medical journals to edit clinical articles and commission medical news stories.

Dr Julia Coombes completed her BSc in Physiology and PhD at the University of Edinburgh. Following this, she took up two post-doctoral research positions at the National Institute for Medical Research (NIMR) and St Mary’s Hospital, Paddington. She joined the MHRA (MCA at the time) in July 1995 as a scientific assessor with the Patient Information Quality Unit. She now manages the Product Information Quality Unit with a team of eleven assessors. The Unit assesses labels and leaflet provided with licensed medicines, Type 1B safety variations and handles complaints and enquiries from healthcare professionals, patients and the pharmaceutical industry.

Dr Max Lagnado graduated with a medical degree from University College London and was a general practitioner before working for the pharmaceutical industry, primarily in medical affairs. At the MHRA, Max assesses the benefit risk of oncology products and assists the Advertising Standards Unit with the assessment of promotional materials.  

Dr Rafe Suvarna worked initially as a clinician and was a medical officer in the RAF from 1989 to 1996, specialising in Aviation Medicine and General Practice.  After leaving the RAF, Rafe worked in the pharmaceutical industry for three years before moving to the then MCA in January 2000 and is currently alternate UK member of the Pharmacovigilance Risk Assessment Committee (PRAC).

Beryl Keeley has a background in biochemistry and has worked in various areas in Government and previously in the pharmaceutical industry. Currently Beryl is Advertising Standards Unit Manager within the Access and Information for Medicines and Standards (AIMS) Group at the Medicines and Healthcare products Regulatory Agency with responsibility for the regulation of medicines advertising.

Claire has recently taken up the post of Advertising Standards and Outreach Unit Manager, having previously worked in this team as the managing editor of Drug Safety Update – the MHRA’s safety bulletin for healthcare professionals. This team aims to ensure that healthcare professionals and the wider public have access to good-quality information about medicines to support safer use. Claire has worked at the Agency for over 10 years in the area of risk communications, helping to draft and release safety information for healthcare professionals and patients on a wide range of topics and medicines. Before coming to the Agency, she studied an MSc in Science Culture and Communication before joining the editorial team at the Lancet group of medical journals to edit clinical articles and commission medical news stories.

Dr Julia Coombes completed her BSc in Physiology and PhD at the University of Edinburgh. Following this, she took up two post-doctoral research positions at the National Institute for Medical Research (NIMR) and St Mary’s Hospital, Paddington. She joined the MHRA (MCA at the time) in July 1995 as a scientific assessor with the Patient Information Quality Unit. She now manages the Product Information Quality Unit with a team of eleven assessors. The Unit assesses labels and leaflet provided with licensed medicines, Type 1B safety variations and handles complaints and enquiries from healthcare professionals, patients and the pharmaceutical industry.

Dr Max Lagnado graduated with a medical degree from University College London and was a general practitioner before working for the pharmaceutical industry, primarily in medical affairs. At the MHRA, Max assesses the benefit risk of oncology products and assists the Advertising Standards Unit with the assessment of promotional materials.  

Dr Rafe Suvarna worked initially as a clinician and was a medical officer in the RAF from 1989 to 1996, specialising in Aviation Medicine and General Practice.  After leaving the RAF, Rafe worked in the pharmaceutical industry for three years before moving to the then MCA in January 2000 and is currently alternate UK member of the Pharmacovigilance Risk Assessment Committee (PRAC).